Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAEAparna Shetty, Sheena G Gupta, Michel Varrin-Doyer, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Multiple Sclerosis and Related Disorders|September 27, 2021
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosisFrederik Novak, Anna Christine Nilsson, Christian Nielsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 5, 2024
Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference ProceedingsKimberly A O'Neill, Andrew Dugue, Nicolas J Abreu, et al.
Nature Communications|September 11, 2015
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentationJae Kyu Ryu, Mark A Petersen, Sara G Murray, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunityJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
Elife|September 28, 2016
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryFeng Mei, Klaus Lehmann-Horn, Yun-An A Shen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part ILarry Steinman, Amit Bar-Or, Jacinta M Behne, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapyJae Kyu Ryu, Elif G Sozmen, Karuna Dixit, et al.
Annals of Clinical and Translational Neurology|February 22, 2023
Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosisBritney Barrera, Haley Simpson, Eric Engebretson, et al.
Pageof 18